Private Trust Company’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $80K | Sell |
152
-8
| -5% | -$4.49K | 0.01% | 1157 |
|
|
2026
Q1 | $89.9K | Sell |
160
-37
| -19% | -$23.7K | 0.01% | 1063 |
|
|
2025
Q4 | $133K | Sell |
197
-12
| -6% | -$8.17K | 0.01% | 906 |
|
|
2025
Q3 | $134K | Buy |
209
+18
| +9% | +$10.9K | 0.01% | 901 |
|
|
2025
Q2 | $102K | Sell |
191
-49
| -20% | -$23.4K | 0.01% | 942 |
|
|
2025
Q1 | $101K | Buy |
240
+42
| +21% | +$18.2K | 0.01% | 944 |
|
|
2024
Q4 | $81.9K | Hold |
198
| – | – | 0.01% | 993 |
|
|
2024
Q3 | $100K | Sell |
198
-10
| -5% | -$4.86K | 0.01% | 922 |
|
|
2024
Q2 | $101K | Buy |
208
+4
| +2% | +$2.01K | 0.01% | 880 |
|
|
2024
Q1 | $110K | Buy |
204
+88
| +76% | +$48.1K | 0.01% | 833 |
|
|
2023
Q4 | $64.4K | Hold |
116
| – | – | 0.01% | 975 |
|
|
2023
Q3 | $50.7K | Sell |
116
-36
| -24% | -$18K | 0.01% | 1006 |
|
|
2023
Q2 | $76.3K | Buy |
152
+34
| +29% | +$16.3K | 0.01% | 894 |
|
|
2023
Q1 | $59K | Buy |
118
+2
| +2% | +$957 | 0.01% | 938 |
|
|
2022
Q4 | $47K | Buy |
116
+4
| +4% | +$1.55K | 0.01% | 976 |
|
|
2022
Q3 | $36K | Hold |
112
| – | – | 0.01% | 1005 |
|
|
2022
Q2 | $39K | Sell |
112
-280
| -71% | -$114K | 0.01% | 1014 |
|
|
2022
Q1 | $214K | Sell |
392
-543
| -58% | -$286K | 0.03% | 331 |
|
|
2021
Q4 | $616K | Sell |
935
-28
| -3% | -$17.6K | 0.09% | 238 |
|
|
2021
Q3 | $599K | Buy |
963
+105
| +12% | +$70.6K | 0.09% | 235 |
|
|
2021
Q2 | $542K | Hold |
858
| – | – | 0.08% | 252 |
|
|
2021
Q1 | $419K | Buy |
858
+43
| +5% | +$21.5K | 0.07% | 273 |
|
|
2020
Q4 | $407K | Buy |
815
+3
| +0.4% | +$1.34K | 0.07% | 271 |
|
|
2020
Q3 | $319K | Buy |
812
+3
| +0.4% | +$1.11K | 0.06% | 283 |
|
|
2020
Q2 | $270K | Buy |
+809
| New | +$234K | 0.06% | 289 |
|
|
2020
Q1 | – | Sell |
-939
| Closed | -$245K | – | 356 |
|
|
2019
Q4 | $245K | Buy |
+939
| New | +$247K | 0.05% | 347 |
|
|
2014
Q3 | – | Sell |
-14
| Closed | -$1K | – | 1972 |
|
|
2014
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 1770 |
|
|
2014
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 1636 |
|
|
2013
Q4 | $1K | Hold |
14
| – | – | ﹤0.01% | 1637 |
|
|
2013
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 1583 |
|
|
2013
Q2 | $1K | Buy |
+14
| New | +$612 | ﹤0.01% | 1528 |
|
Other funds holding IDXX
Private Trust Company's IDXX Position: Q2 2026 in Review
Private Trust Company reduced its Idexx Laboratories (IDXX) stake by 5% in Q2 2026, selling an estimated $4.49K and leaving 152 shares worth $80K. The position accounts for 0.01% of the portfolio, ranked #1157.
Private Trust Company first reported a position in IDXX in Q2 2013 and has held it in 31 quarters since. The position peaked at $616K in Q4 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Private Trust Company held 152 shares of Idexx Laboratories worth $80K as of Q2 2026.
- Private Trust Company sold 8 Idexx Laboratories shares in Q2 2026, an estimated $4.49K.
- Idexx Laboratories made up 0.01% of Private Trust Company's portfolio in Q2 2026, its #1157 holding.
- Private Trust Company first reported a position in Idexx Laboratories in Q2 2013 and has held it in 31 quarters since.
- Private Trust Company's Idexx Laboratories position peaked at $616K in Q4 2021.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.